Strata Critical Medical, Inc. (SRTA) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for SRTA is $7.25, representing a +67.4% upside from the current price of $4.33. Price targets range from a low of $7.25 to a high of $7.25.
